AKRO•benzinga•
Looking Into Akero Therapeutics's Recent Short Interest
Summary
Akero Therapeutics's (NASDAQ:AKRO) short percent of float has risen 6.59% since its last report. The company recently reported that it has 6.18 million shares sold short, which is 20.38% of all regular shares that are available for trading.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 13, 2022 by benzinga